跳至主要内容
临床试验/NCT07093736
NCT07093736已完成不适用

A Randomized Waitlist-controlled Trial to Evaluate of the Effectiveness of Immediate Treatment Compared to Deferred Treatment With the Fisher Wallace Stimulator FW-200 Device in First Responders With Self-reported Anxiety

Fisher Wallace Laboratories4 个研究点 分布在 1 个国家目标入组 220 人开始时间: 2021年7月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
220
试验地点
4
主要终点
Beck Anxiety Inventory (BAI) scores

研究概览

简要总结

The goal of this clinical trial is to learn if the Fisher Wallace Stimulator FW-200 experimental device is effective at treating self-reported anxiety in first responders. The main question the trial aims to answer is does the FW-200 device improve anxiety as measured by a validated questionnaire.

详细描述

This is a randomized waitlist-controlled trial to evaluate the efficacy and safety of the Fisher Wallace Stimulator FW-200 device in the treatment of self-reported anxiety in police personnel and first responders. Participants will be randomly assigned to receive immediate treatment or deferred treatment with the FW-200 device.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 years and older
  • Ability to read and write in English
  • First responder employee or employee of participating police department
  • Beck Anxiety Inventory total score above 7
  • Able to commit to two 20-minute device treatment session per day for up to 8 weeks
  • Willing to wear an actigraphy device

排除标准

  • Use of brain stimulation device in the last year
  • Have a pacemaker, electronic stent or electronic implants
  • Started or planning to start new medial treatment or health program over the next 8 weeks
  • Contemplated suicide in the past year
  • Institutionalized for mental health issues
  • Have a serious medical condition
  • Currently taking medications affecting the nervous system
  • Allergic to nickel
  • Currently taking or planning to take part in any other study on insomnia, anxiety or other mental health effort over the next 8 weeks
  • Currently pregnant or planning to become pregnant in the next 10 weeks

结局指标

主要结局

Beck Anxiety Inventory (BAI) scores

时间窗: From baseline to week 2

Change in Beck Anxiety Inventory (BAI) scores at Week 2 versus baseline in immediate treatment group compared to the deferred treatment group. Total score range is a minimum of 0 to a maximum of 63. Higher score means a worse severity of anxiety.

次要结局

  • Consenting to Study Continuation(Week 4)
  • Patient Health Questionnaire(From baseline to week 2 and week 4. Total scores range from 0 to 24. Higher scores mean worse severity of depressive symptoms.)
  • Professional Quality of Life(From baseline to week 2 and week 4)
  • Total Sleep Time(Baseline to through study completion)

研究者

发起方
Fisher Wallace Laboratories
申办方类型
Industry
责任方
Principal Investigator
主要研究者

Lois James, Ph.D.

Associate Professor, WSU College of Nursing

Fisher Wallace Laboratories

研究点 (4)

Loading locations...

相似试验